Sheba ARC Innovation Center’s Starget Pharma Secures $5.1M to Advance AI-Powered Cancer Radiotherapy
Starget Pharma was co-founded by CEO Sigal Clemenson-Kushnir and Chairman Ronen Clemenson in 2019. The company leverages the expertise and support from Sheba Medical Center’s ARC Innovation Center. This innovative startup specializes in radioligand therapies that target cancer cells with precision, sparing healthy tissues and providing a more targeted and efficient solution compared to conventional radiation treatments.
Revolutionizing Oncology with AI Technology
Starget Pharma’s proprietary platform integrates advanced AI technology with diagnostic imaging to create personalized treatment plans for patients with advanced cancers.
“Our technology offers a significant alternative to existing therapies, particularly for patients facing advanced cancer with limited treatment options,” said Sigal Clemenson-Kushnir.
A Global Collaboration in Cancer Care
The $5.1M in funding from Cancer Focus, a fund supported by MD Anderson Cancer Center, will enable Starget Pharma to begin clinical trials in early 2025. These trials will evaluate the safety and efficacy of their targeted radioligand therapies for treating advanced cancers such as melanoma, sarcomas, neuroendocrine tumors, and liver cancer. The trials will take place at MD Anderson and other leading institutions, marking a significant step forward in bringing this innovative treatment to patients worldwide.
Starget Pharma’s journey began at Sheba Medical Center’s ARC Innovation Center, which played a crucial role in supporting the early-stage development of the company and its cutting-edge cancer therapies. Sheba’s involvement has been central to Starget Pharma’s success, demonstrating the power of collaboration between innovative startups, renowned medical institutions, and global research leaders in the fight against cancer.
More Posts
Sheba’s Prof. Amitai Ziv Awarded by IMSH for Medical Simulation Excellence
Prof. Amitai Ziv, Founder of MSR-Azrieli Medical Simulation Center and Director of the Rehabilitation Hospital at Sheba Medical Center, has received...
Sheba’s Physicians Sweep Forbes Israel’s 2025 “Best Doctors” List
Forbes Israel has named an exceptional number of Sheba Medical Center’s physicians on its 2025 “Best Doctors” list. Earlier this year, Sheba was ranked by Newsweek as one of the World’s Top 10 Hospitals. This recognition and alignment between institutional and individual excellence signals to the global medical community that Sheba concentrates many of Israel’s most trusted clinical leaders under one roof.
Twinning and Training: Scalable Solutions for Global Eye Cancer Equity
Sheba Global Ophthalmology (SGO) demonstrates how sustainable twinning and hands-on training create self-reliant ocular oncology capacity in low- and middle-income countries (LMICs), far surpassing the limitations of short-term outreach.
